vTv Therapeutics(VTVT) - 2021 Q4 - Annual Report

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) vTv Therapeutics Inc. For the fiscal year ended December 31, 2021 (Exact name of registrant as specified in its charter) Or Delaware 47-3916571 (State or other jurisdiction of incorporation or organization) 3980 Premier Dr, Suite 310 High Point, NC 27265 (Address of principal executive offices) (Zip Code) ☐ TRANSITION REPORT PURSU ...